Leadoptik has entered a research partnership with Stanford Medicine, focusing on real-time optical imaging usage in lung ...

India's first AI-led Incidental Pulmonary Nodule Detection Clinic opens at Thangam Cancer Centre, Tamil Nadu. Part of Project ...

Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

At-home cancer screening kits, particularly those for colon cancer, have gained traction in recent years. “To my knowledge, ...

For the first time, scientists have systematically analyzed somatic mutations in stomach lining tissue to unpick mutational ...

NEW YORK – Cancer diagnostics firm AccuStem Sciences announced on Tuesday that it has acquired the license for the proprietary MicroRNA Signature Classifier (MSC) test for lung cancer screening from ...

In another case study, CyPath® Lung helped physicians identify and treat a recurrence of breast cancer in a high-risk patient.

Clinical stage diagnostics company AccuStem Sciences has acquired the licence for the microRNA Signature Classifier (MSC) ...

Qure.ai, a global leader in artificial intelligence (AI) for healthcare, today announced the launch of India’s first AI-led ...

Lung cancer is the leading cause of cancer-related deaths worldwide, accounting for more deaths than breast, colon, and prostate cancers combined. With those sobering stats, any medical advancement / ...

A multicenter study has shown that lymph node transfer is a viable treatment for the swelling in the affected limb, a condition known as lymphedema, after breast cancer surgery. However, an effective ...

AccuStem pursuing strategic commercialization plan intending to launch the MSC test in the US in 2026LONDON and PHOENIX, Ariz., March 18, 2025 ...